Výsledky vyhľadávania - "Cost-effectiveness"

Cost-effectiveness of CMR over MPS-SPECT: a systematic review of recent trends for diagnosing CAD.

Autori: Kluge B Harris J Sánchez-Collado I a ďalší

Zdroj: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 1451-1466. Date of Electronic Publication: 2025 Sep 10.

Spôsob vydávania: Comparative Study; Journal Article; Systematic Review

Informácie o časopise: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

Výrazy zo slovníka MeSH: Coronary Artery Disease*/diagnostic imaging , Coronary Artery Disease*/diagnosis , Magnetic Resonance Imaging*/economics , Magnetic Resonance Imaging*/methods , Myocardial Perfusion Imaging*/economics , Myocardial Perfusion Imaging*/methods , Tomography, Emission-Computed, Single-Photon*/economics , Tomography, Emission-Computed, Single-Photon*/methods , Cost-Effectiveness Analysis*, Humans ; Quality-Adjusted Life Years

Cost-Effectiveness of Endovascular Thrombectomy in Large Vessel Occlusion Stroke for the Very Elderly.

Autori: Lee P Wu T Chen C a ďalší

Korporácia: Lee P Wu T Chen C a ďalší

Zdroj: Neurology [Neurology] 2025 Nov 11; Vol. 105 (9), pp. e214079. Date of Electronic Publication: 2025 Oct 03.

Spôsob vydávania: Journal Article; Multicenter Study; Observational Study

Informácie o časopise: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

Výrazy zo slovníka MeSH: Endovascular Procedures*/economics , Endovascular Procedures*/methods , Ischemic Stroke*/economics , Ischemic Stroke*/surgery , Thrombectomy*/economics , Thrombectomy*/methods , Cost-Effectiveness Analysis*, Aged, 80 and over ; Female ; Humans ; Male ; Australia ; New Zealand ; Quality-Adjusted Life Years ; Retrospective Studies ; Treatment Outcome

Cost-Effectiveness of Single Versus Multiple Sessions of Physical Therapy for Adults With Spinal Disorders: An Economic Evaluation From a Pragmatic Randomized Controlled Trial.

Autori: Lafrance S Thavorn K Desmeules F a ďalší

Zdroj: The Journal of orthopaedic and sports physical therapy [J Orthop Sports Phys Ther] 2025 Nov; Vol. 55 (11), pp. 1-8.

Spôsob vydávania: Journal Article; Pragmatic Clinical Trial

Informácie o časopise: Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 7908150 Publication Model: Print Cited Medium: Internet ISSN: 1938-1344 (Electronic) Linking ISSN: 01906011 NLM ISO Abbreviation: J Orthop Sports Phys Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Physical Therapy Modalities*/economics , Spinal Diseases*/therapy , Spinal Diseases*/economics , Spinal Diseases*/rehabilitation , Cost-Effectiveness Analysis*, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Exercise Therapy/economics ; Exercise Therapy/methods ; Health Care Costs ; Quality-Adjusted Life Years

Cost-Effectiveness of an Enhanced Patient Care Intervention for Improving Viral Suppression Among Kenyan Adults Living With HIV.

Autori: Fritz J Wachira J Wilson-Barthes M a ďalší

Zdroj: Value in health regional issues [Value Health Reg Issues] 2025 Sep; Vol. 49, pp. 101129. Date of Electronic Publication: 2025 May 21.

Spôsob vydávania: Journal Article; Randomized Controlled Trial

Informácie o časopise: Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-1102 (Electronic) Linking ISSN: 22121099 NLM ISO Abbreviation: Value Health Reg Issues Subsets: MEDLINE

Výrazy zo slovníka MeSH: HIV Infections*/drug therapy , HIV Infections*/therapy , Patient Care*/methods , Patient Care*/standards , Viral Load* , Cost-Effectiveness Analysis*, Adult ; Female ; Humans ; Male ; Middle Aged ; Anti-HIV Agents/therapeutic use ; Kenya ; Patient-Centered Care/economics ; Pilot Projects

Addressing Subgroup-Specific Treatment Effects to Avoid Inefficient Care: The Conflict Between Statistical and Health Economic Analyses.

Autori: Saing S Hannink G Geuzinge HA a ďalší

Zdroj: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2025 Aug; Vol. 28 (8), pp. 1145-1152. Date of Electronic Publication: 2025 May 23.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

Výrazy zo slovníka MeSH: Computer Simulation* , Reimbursement Mechanisms*/economics , Cost-Effectiveness Analysis*, Humans ; Decision Support Techniques ; Markov Chains ; Models, Economic ; Quality-Adjusted Life Years

Cost-Effectiveness of In-Bed Cycling and Routine Physiotherapy for Patients Receiving Mechanical Ventilation.

Autori: Tarride JE Blackhouse G Rochwerg B a ďalší

Korporácia: Tarride JE Blackhouse G Rochwerg B a ďalší

Zdroj: JAMA network open [JAMA Netw Open] 2025 Sep 02; Vol. 8 (9), pp. e2529399. Date of Electronic Publication: 2025 Sep 02.

Spôsob vydávania: Journal Article; Multicenter Study; Randomized Controlled Trial

Informácie o časopise: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Výrazy zo slovníka MeSH: Bicycling* , Physical Therapy Modalities*/economics , Respiration, Artificial*/economics , Cost-Effectiveness Analysis*, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Australia ; Canada ; Intensive Care Units/economics ; Quality-Adjusted Life Years ; United States

Costs and cost-effectiveness of integrated horizontal community health worker programmes in low- and middle-income countries (2015-2024): a scoping literature review.

Autori: O' Donovan J Kumar MB Ballard M a ďalší

Zdroj: BMJ global health [BMJ Glob Health] 2025 Jul 22; Vol. 10 (7). Date of Electronic Publication: 2025 Jul 22.

Spôsob vydávania: Journal Article; Scoping Review

Informácie o časopise: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101685275 Publication Model: Electronic Cited Medium: Print ISSN: 2059-7908 (Print) Linking ISSN: 20597908 NLM ISO Abbreviation: BMJ Glob Health Subsets: MEDLINE

Výrazy zo slovníka MeSH: Community Health Workers*/economics , Developing Countries* , Primary Health Care*/economics , Cost-Effectiveness Analysis*, Humans

Cost-effectiveness of long-acting cabotegravir/rilpivirine for people with HIV and adherence challenges at the Ward 86 clinic: an intermediate outcome analysis.

Autori: Marseille E Walker RS Hickey MD a ďalší

Zdroj: AIDS (London, England) [AIDS] 2025 Jun 01; Vol. 39 (7), pp. 899-904. Date of Electronic Publication: 2025 Feb 04.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

Výrazy zo slovníka MeSH: Cost-Effectiveness Analysis* , HIV Infections*/drug therapy , Pyridones*/economics , Pyridones*/therapeutic use , Diketopiperazines*/economics , Diketopiperazines*/therapeutic use , Rilpivirine*/economics , Rilpivirine*/therapeutic use , Antiviral Agents*/economics , Antiviral Agents*/therapeutic use, Assessment of Medication Adherence ; HIV Integrase Inhibitors/economics ; HIV Integrase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/economics ; Reverse Transcriptase Inhibitors/therapeutic use ; Humans ; Treatment Outcome

Cost-Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK.

Autori: Galekop MMJ Calder PC Baker EJ a ďalší

Zdroj: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association [J Hum Nutr Diet] 2025 Jun; Vol. 38 (3), pp. e70071.

Spôsob vydávania: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

Informácie o časopise: Publisher: Wiley on behalf of The British Dietetic Association Ltd., [c1988- Country of Publication: England NLM ID: 8904840 Publication Model: Print Cited Medium: Internet ISSN: 1365-277X (Electronic) Linking ISSN: 09523871 NLM ISO Abbreviation: J Hum Nutr Diet Subsets: MEDLINE

Výrazy zo slovníka MeSH: Obesity*/economics , Obesity*/prevention & control , Obesity*/therapy , Obesity*/diet therapy , Overweight*/economics , Overweight*/therapy , Overweight*/diet therapy , Overweight*/prevention & control , Precision Medicine*/economics , Cost-Effectiveness Analysis*, Adult ; Female ; Humans ; Male ; Middle Aged ; Body Mass Index ; Poland ; Quality of Life ; Quality-Adjusted Life Years ; United Kingdom

Cost-Effectiveness Analysis of SOX Plus Bevacizumab Versus SOX Plus Cetuximab for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer in Japan.

Autori: Morimoto T Fujito K Goto R

Zdroj: Clinical therapeutics [Clin Ther] 2025 May; Vol. 47 (5), pp. 347-354. Date of Electronic Publication: 2025 Mar 03.

Spôsob vydávania: Journal Article; Comparative Study

Informácie o časopise: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Cost-Effectiveness Analysis* , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/economics , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/economics , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Proto-Oncogene Proteins p21(ras)*/genetics, Oxaliplatin/economics ; Oxaliplatin/therapeutic use ; Bevacizumab/economics ; Bevacizumab/therapeutic use ; Cetuximab/economics ; Cetuximab/therapeutic use ; Antimetabolites, Antineoplastic/economics ; Antimetabolites, Antineoplastic/therapeutic use ; Antineoplastic Agents, Immunological/economics ; Antineoplastic Agents, Immunological/therapeutic use ; Progression-Free Survival ; Quality-Adjusted Life Years ; Patient Selection ; Precision Medicine/economics ; Precision Medicine/methods ; Japan/epidemiology ; Randomized Controlled Trials as Topic ; Clinical Trials, Phase II as Topic ; Multicenter Studies as Topic ; Drug Costs ; Treatment Outcome ; Humans ; Neoplasm Metastasis

Cost-Effectiveness of Functional Family Therapy for Youth Probationers in Singapore: Findings From a Randomized Controlled Trial.

Autori: Fang L Cai SY Latiff MA a ďalší

Zdroj: Journal of marital and family therapy [J Marital Fam Ther] 2025 Apr; Vol. 51 (2), pp. e70017.

Spôsob vydávania: Journal Article; Randomized Controlled Trial

Informácie o časopise: Publisher: Blackwell Country of Publication: United States NLM ID: 7904614 Publication Model: Print Cited Medium: Internet ISSN: 1752-0606 (Electronic) Linking ISSN: 0194472X NLM ISO Abbreviation: J Marital Fam Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Criminals* , Family Therapy*/economics , Family Therapy*/methods , Juvenile Delinquency*/rehabilitation , Juvenile Delinquency*/economics , Recidivism*/economics , Recidivism*/prevention & control , Cost-Effectiveness Analysis*, Adolescent ; Female ; Humans ; Male ; Young Adult ; Singapore

The clinical and cost effectiveness of a STAndardised DIagnostic Assessment for children and adolescents with emotional difficulties: the STADIA multi-centre randomised controlled trial.

Autori: Sayal K Wyatt L Partlett C a ďalší

Zdroj: Journal of child psychology and psychiatry, and allied disciplines [J Child Psychol Psychiatry] 2025 Jun; Vol. 66 (6), pp. 805-820. Date of Electronic Publication: 2025 Jan 07.

Spôsob vydávania: Journal Article; Multicenter Study; Pragmatic Clinical Trial

Informácie o časopise: Publisher: Blackwell Publishers Country of Publication: England NLM ID: 0375361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-7610 (Electronic) Linking ISSN: 00219630 NLM ISO Abbreviation: J Child Psychol Psychiatry Subsets: MEDLINE

Výrazy zo slovníka MeSH: Affective Symptoms*/diagnosis , Affective Symptoms*/economics , Cost-Effectiveness Analysis* , Mental Health Services*/economics, Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Male ; England

Efficiency of periodontal treatment to improve type 2 diabetes mellitus outcomes: A systematic review and meta-analysis of economic evaluations.

Autori: Sáenz-Ravello G Castillo-Riquelme M Cuadrado C a ďalší

Zdroj: Community dentistry and oral epidemiology [Community Dent Oral Epidemiol] 2025 Apr; Vol. 53 (2), pp. 135-151. Date of Electronic Publication: 2024 Aug 16.

Spôsob vydávania: Journal Article; Meta-Analysis; Systematic Review

Informácie o časopise: Publisher: Munksgaard International Publishers Country of Publication: Denmark NLM ID: 0410263 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0528 (Electronic) Linking ISSN: 03015661 NLM ISO Abbreviation: Community Dent Oral Epidemiol Subsets: MEDLINE

Výrazy zo slovníka MeSH: Diabetes Mellitus, Type 2*/economics , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/therapy , Periodontitis*/therapy , Periodontitis*/economics , Periodontitis*/complications , Cost-Effectiveness Analysis*, Humans ; Health Care Costs ; Treatment Outcome

Cost Effectiveness of Colorectal Cancer Screening Strategies in Middle- and High-Income Countries: A Systematic Review.

Autori: Li Y Xia R Si W a ďalší

Zdroj: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2025 Mar; Vol. 40 (3), pp. 584-598. Date of Electronic Publication: 2025 Jan 16.

Spôsob vydávania: Journal Article; Systematic Review

Informácie o časopise: Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1746 (Electronic) Linking ISSN: 08159319 NLM ISO Abbreviation: J Gastroenterol Hepatol Subsets: MEDLINE

Výrazy zo slovníka MeSH: Colorectal Neoplasms*/diagnosis , Colorectal Neoplasms*/economics , Cost-Effectiveness Analysis* , Developed Countries*/economics , Early Detection of Cancer*/economics , Early Detection of Cancer*/methods , Mass Screening*/economics , Mass Screening*/methods, Humans ; Colonography, Computed Tomographic/economics ; Colonoscopy/economics ; Developing Countries/economics ; Occult Blood ; Sigmoidoscopy/economics

Cost-effectiveness analysis of metagenomic next-generation sequencing versus traditional bacterial cultures for postoperative central nervous system infections in critical care settings: a prospective pilot study.

Autori: Tian Y Xu N Chen Y a ďalší

Zdroj: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2025 Oct 28; Vol. 15, pp. 1710412. Date of Electronic Publication: 2025 Oct 28 (Print Publication: 2025).

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE

Výrazy zo slovníka MeSH: Cost-Benefit Analysis* , High-Throughput Nucleotide Sequencing*/economics , High-Throughput Nucleotide Sequencing*/methods , Central Nervous System Infections*/diagnosis , Central Nervous System Infections*/microbiology , Central Nervous System Infections*/economics , Metagenomics*/economics , Metagenomics*/methods , Critical Care*/economics , Bacteria*/genetics , Bacteria*/isolation & purification , Bacteria*/classification , Postoperative Complications*/microbiology , Postoperative Complications*/diagnosis , Bacteriological Techniques*/economics , Bacteriological Techniques*/methods, Humans ; Pilot Projects ; Prospective Studies ; Female ; Male ; Middle Aged ; Aged ; Adult ; Intensive Care Units ; China ; Cost-Effectiveness Analysis

Within-trial cost-effectiveness of novel macrophage-regulating treatment on wound healing in patients with diabetic foot ulcers.

Autori: Su HY Yang CY Chang YH a ďalší

Zdroj: Journal of food and drug analysis [J Food Drug Anal] 2025 Mar 31; Vol. 33 (1), pp. 21-30.

Spôsob vydávania: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

Informácie o časopise: Publisher: Food and Drug Administration, Taiwan Country of Publication: China (Republic : 1949- ) NLM ID: 101630927 Publication Model: Print Cited Medium: Internet ISSN: 2224-6614 (Electronic) NLM ISO Abbreviation: J Food Drug Anal Subsets: MEDLINE

Výrazy zo slovníka MeSH: Diabetic Foot*/drug therapy , Diabetic Foot*/economics , Diabetic Foot*/immunology , Macrophages*/drug effects , Macrophages*/immunology , Wound Healing*/drug effects , Cost-Effectiveness Analysis*, Aged ; Female ; Humans ; Male ; Middle Aged ; Taiwan ; Plant Extracts/administration & dosage ; Plant Extracts/economics ; Skin Cream/administration & dosage ; Skin Cream/economics

European guidelines for the management of tuberculosis screening procedures in migrants: A systematic review.

Autori: Pinheiro M Valente C Cruz M a ďalší

Zdroj: Pulmonology [Pulmonology] 2025 Dec 31; Vol. 31 (1), pp. 2482855. Date of Electronic Publication: 2025 Apr 02.

Spôsob vydávania: Journal Article; Systematic Review

Informácie o časopise: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101723786 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-0437 (Electronic) Linking ISSN: 25310429 NLM ISO Abbreviation: Pulmonology Subsets: MEDLINE

Výrazy zo slovníka MeSH: Mass Screening*/economics , Mass Screening*/methods , Mass Screening*/standards , Transients and Migrants*/statistics & numerical data , Tuberculosis*/diagnosis , Tuberculosis*/economics , Tuberculosis*/epidemiology , Tuberculosis*/prevention & control , Communicable Diseases, Imported*/diagnosis , Communicable Diseases, Imported*/economics , Communicable Diseases, Imported*/epidemiology , Communicable Diseases, Imported*/prevention & control, Humans ; Cost-Effectiveness Analysis ; Europe/epidemiology ; Practice Guidelines as Topic

Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial.

Autori: Wortelboer N Kent S Konings IR a ďalší

Zdroj: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Dec 09; Vol. 231, pp. 116051. Date of Electronic Publication: 2025 Oct 25.

Spôsob vydávania: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Informácie o časopise: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Výrazy zo slovníka MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/economics , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Cyclin-Dependent Kinase 6*/antagonists & inhibitors , Cyclin-Dependent Kinase 4*/antagonists & inhibitors , Protein Kinase Inhibitors*/economics , Protein Kinase Inhibitors*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/economics, Humans ; Female ; Cost-Benefit Analysis ; Quality-Adjusted Life Years ; Middle Aged ; Aged ; Cost-Effectiveness Analysis

Cost-effectiveness analysis of ribociclib versus abemaciclib as first-line treatments for postmenopausal women with HR+/HER2- advanced breast cancer: a Medicare perspective.

Autori: Tarantino P Sammons S Gadi VK a ďalší

Zdroj: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 2125-2134. Date of Electronic Publication: 2025 Dec 05.

Spôsob vydávania: Journal Article

Informácie o časopise: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

Výrazy zo slovníka MeSH: Aminopyridines*/economics , Aminopyridines*/therapeutic use , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Benzimidazoles*/economics , Benzimidazoles*/therapeutic use , Purines*/economics , Purines*/therapeutic use , Antineoplastic Agents*/economics , Antineoplastic Agents*/therapeutic use, Humans ; Female ; Cost-Benefit Analysis ; United States ; Quality-Adjusted Life Years ; Medicare/economics ; Postmenopause ; Aged ; Receptor, ErbB-2 ; Cost-Effectiveness Analysis

Cost-effectiveness analysis of anlotinib plus penpulimab versus sorafenib in the treatment of unresectable hepatocellular carcinoma.

Autori: Luo J Li Z Gui C a ďalší

Zdroj: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2582294. Date of Electronic Publication: 2025 Dec 01.

Spôsob vydávania: Journal Article; Comparative Study

Informácie o časopise: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

Výrazy zo slovníka MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/economics , Cost-Benefit Analysis* , Sorafenib*/economics , Sorafenib*/therapeutic use , Sorafenib*/administration & dosage , Liver Neoplasms*/drug therapy , Liver Neoplasms*/economics , Quinolines*/economics , Quinolines*/therapeutic use , Quinolines*/administration & dosage , Indoles*/economics , Indoles*/therapeutic use , Indoles*/administration & dosage , Antineoplastic Agents*/economics , Antineoplastic Agents*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/economics , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Quality-Adjusted Life Years ; China ; Male ; Cost-Effectiveness Analysis ; Antibodies, Monoclonal, Humanized